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anemia). The patients were followed up for 23 months, from January
of 2011 to December of 2013. All the patients went through surgical
repair or percutaneous leak closure (Amplatzer AVP II). Primarily, we
analyzed the epidemiological data related with paravalvular pros-
thetic regurgitation; sequentially the patients were divided into two
treatment groups, percutaneous leak closure or surgical repair. Finally
we analyzed the clinical outcomes during hospitalization and up to 1
year.
RESULTS The median age at the time of diagnosis was 54  14 years,
71.4% of whom were men. The mitral valve had a higher incidence of
paravalvular leak (60%) and was more common in biological valve
prostheses (51.4%). We report 10 patients (28.6%) in the percuta-
neous leak closure group, and 25 patients (71.4%) in the surgical
repair group. The percutaneous leak closure group had patients of
higher risk, older patients (63  13 vs. 54  14, p¼0.011), higher
prevalence of diabetes (30% vs. 0%, p¼ 0.018), increase number of
previous surgeries (2.6  1 vs. 1.72  0.7, p¼0.04) and lower creati-
nine clearance (Cockcroft-Gault Equation) (72  38 vs. 90  38,
p¼0.07). The clinical presentation was heart failure class III by New
York Heart Association classiﬁcation (40%) and hemolytic anemia
(42%). During hospitalization we report 74.3% of complications in
the both groups, the surgical repair group had more bleeding com-
plications (48% vs. 30%, p¼0.45) and infection (36% vs. 10%,
p¼0.21), however this complications did not have statistical signiﬁ-
cance when clinical outcomes were analyzed between the groups. At
1 year follow up, mortality (0% vs. 20%, p¼0.08) did not have sta-
tistical signiﬁcance.
CONCLUSIONS Symptomatic paravalvular prosthetic regurgitation is
an uncommon yet serious complication more associated with mitral
valve and biological prostheses. Surgical repair is the best treatment
option; however percutaneous leak closure is a promising treatment
in high risk patients. There is a need of development of new devices
for this pathology. Our study showed no difference in clinical out-
comes between the two groups; however we did not have a large
number of patients.
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BACKGROUND The Use of retrograde femoral access to close Mitral
Paravalvular Leakage (MPVL) in patients with the combination of
aortic and mitral metallic prostheses has considered contraindicated.
The aim of this study was to assess the safety and feasibility of
Percutaneous Closure of MPVL in patients with double aortic and
metallic prostheses.
METHODS Consecutive patients with double prosthesis (DP) who
underwent percutaneous MPVL closure in our institution were
included. Anterograde and retrograde approach consisting of crossing
the wire across the aortic prosthesis in order to access and cross the
perivalvular mitral leak were used. Arterious venous loop (AVL) were
also performed in all cases but one. The device used in all in-
terventions were Amplatzer Vascular Plug III. Immediate and mid-
term follow-up results were analyzed.
RESULTS From February 2009 to December 2014, 56 patients under-
went MPVL in our institution. Twenty ﬁve patients (44.6%) had
double prosthetic mitral and aortic valve (DP). Mean age was 69 11.
40% were male. The mean clinical follow up was 416.5323.1 days
Retrograde approach with AVL was performed in 17 patients (68%). All
procedures were hemodynamically well tolerated. Technical success
rates were 88%, (2 patients needed two procedures). One patient had
device embolization that was percutaneously captured and a second
device was successfully implanted in the same procedure and 1 pa-
tient needed emergency surgery due to disc interference. At follow-up
50% of the patients presented signiﬁcant NYHA functional classimprovement. Seven patients (28%) died during follow-up due to
persistent cardiac failure.
CONCLUSIONS Percutaneous Closure of MPVL in patients with dou-
ble aortic and mitral prosthesis can be done safely considering few
tips are taking into consideration during the procedure.
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BACKGROUND Percutaneous treatment of mitral regurgitation (MR)
is an option for patients facing a high operative risk. The inﬂuence of
percutaneous edge-to-edge mitral valve repair (PMVR) on the mitral
valve (MV) geometry is not yet clearly understood. We herein in
present a novel four-dimensional echocardiography based computa-
tional model to assess morphologic MV changes during the complete
cardiac cycle before and after edge-to-edge MV repair.
METHODS Twenty-eight consecutive patients (mean age 77  8 years)
underwent elective PMVR for mitral regurgitation with the MitraClip
device. Periprocedural RT3DTEE data were analyzed using a semi-
automated MV modeling software (eSie Valves) focusing on MV
oriﬁce area, commissural diameter, antero-posterior diameter, ante-
rolateral-posteriomedial diameter, annular area, annular circumfer-
ence and annular height throughout the entire cardiac cycle in 10%
steps.
RESULTS PMVR led to a reduction in MV oriﬁce area (4.61.9 and
1.50.5 cm2; P<0,001) and a postponed opening of the MV leaﬂets in
diastole (20 and 35% of cardiac cycle). The anterior-posterior diameter
was reduced signiﬁcantly (34.55.0 and 31.93.8 mm; P<0.001)
whereas the anterolateral-posteromedial and commissural diameter
increased in diastole (39.75.0 and 42.34.6 mm; P<0,001 and
38.84.9 and 41.04.3 mm; P<0,001), respectively. No signiﬁcant
changes were detected for annular area, annular circumference and
annular height.
CONCLUSIONS Four-dimensional analysis after PMVR depicts sig-
niﬁcant changes in the MV geometry. Furthermore not yet detected
changes of MV opening and closing are presented. To the best of our
knowledge this is the ﬁrst 4-dimensional analysis of MV before and
after PMVR.
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